Hemostasis Today

November, 2026
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Does a Higher Measured Factor Level Always Mean Better Protection Against Joint Bleeds? – Global Hemophilia Report
Nov 19, 2026, 10:58

Does a Higher Measured Factor Level Always Mean Better Protection Against Joint Bleeds? – Global Hemophilia Report

Global Hemophilia Report shared a post on LinkedIn:

“Does a higher measured factor level always mean better protection against joint bleeds?

On the latest Global Hemophilia Report, Dr. Steven Pipe examines the uncertainty around factor VIII and IX levels needed to prevent joint bleeding, including whether higher assay results in patients receiving non-factor therapy translate to better bleeding protection.

Listen in for a closer look at the evidence gaps shaping treatment decisions in hemophilia care.

Guests:

  • Steven Pipe, MD – Hematologist, Professor of Pediatrics and Pathology, University of Michigan
  • Len Valentino, MD – President, World Federation of Hemophilia USA
  • Kenneth Friedman, MD – Senior Medical Director, Hematology, Versiti Blood Center of Wisconsin

Hosted by: Patrick James Lynch

Supported through advertising by Sanofi.”

Proceed to the video attached to the post.

Find more posts featuring Global Hemophilia Report on Hemostasis Today.